Allergy Therapeutics announces publication of positive data of Pollinex Quattro Grass vaccines

03:31 EDT 25 Jun 2018 | Proactive Investors

The company said each of the clinical symptoms (runny nose, sneezing and conjunctivitis) were statistically significantly reduced in treated patients compared with controls without allergen-specific immunotherapy

More From BioPortfolio on "Allergy Therapeutics announces publication of positive data of Pollinex Quattro Grass vaccines"